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A highly sensitive and specific radioimmunoassay for the head activator has been developed which utilises 
tritiated head activator. The assay is sensitive in the range of 40-200 fmol. Immunochemical studies 
showed that the antiserum recognised the intact molecule better than any of the fragments or derivatives 
produced by enzymatic treatment or chemical synthesis. 
Radioimmunoassay Hydra head activator 
1. INTRODUCTION 
The head activator (HA) is a biologically active 
peptide which was isolated and sequenced from 
different coelenterates such as hydra, sea 
anemones and also from mammalian brain and in- 
testine [ 1,2]. In these various species and tissues 
the same sequence pGlu-Pro-Pro-Gly-Gly- 
Ser-Lys-Val-Ile-Leu-Phe was found. In hydra 
this peptide acts as head inducing morphogen at 
lo-l3 M, in mammals it affects stimulation of ex- 
ocrine pancreas secretion at lo-” M [3]. 
Up to now the HA was assayed in the normal 
HA assay measuring the stimulation of head and 
bud formation in hydra [4]. Although being very 
sensitive, both assays are extremely laborious and 
time consuming. This work describes the establish- 
ment of a radioimmunoassay (RIA), which enables 
us to determine the concentration of immunoreac- 
tive HA within a relatively short time (2 days) and 
with a very high degree of precision. 
2. MATERIALS AND METHODS 
2.1. Preparation of the antigenic conjugate 
Trifluoroethanol (200~1) were added to 5.5 mg 
HA (Bachem) to solubilise the hydrophobic pep- 
tide. This solution was slowly diluted with 1.5 ml 
Tritiated head activator Neuropeptide HPLC 
water, and 22.5 mg of keyhole limpet hemocyanin 
(Calbiochem) were added. After an intermittent 
addition of 1 ml I-ethyl-3-(3-dimethylaminopro- 
pyl)-carbodiimide-HCl (20 mg/ml, Calbiochem) 
over 1 h [5] the mixture was stirred overnight at 
22°C and dialysed afterwards against 3 changes of 
1 1 of 0.15 M NaCI. 
2.2. Itnmunisation 
Specific pathogenic free hybrid rabbits 
(2.5-3 kg) were immunised with 500~1 antigenic 
conjugate containing an equivalent of 110 tg pep- 
tide and an equal volume of Freund’s complete ad- 
juvant. One half of this mixture was injected 
directly into the lymphnodes of the knees. The 
lymphnodes had been made visible before with 
Evans blue @OOpl/knee) and exposed under 
anaesthesia (phentanyl, 2 ml/kg). The rest of the 
mixture was injected intradermally over 10 sites in- 
to the backs of the rabbits. The rabbits were 
boosted at monthly intervals with 500~1 of con- 
jugate and serum was obtained 5 days after each 
injection. For a first analysis of antibody titer the 
sera were assayed in an enzyme-linked immunosor- 
bent assay (unpublished). 
2.3. Preparation of the tracer 
[3,4-dehydropro2”]HA (Bachem) was catalytic- 
ally tritiated by Amersham. The tritiated product 
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was heterogenous and therefore purified according 
to the following procedure: HA specific antiserum, 
after purification on protein A-Sepharose, was 
bound to 1.5 g CNBr-activated Sepharose 4B as 
recommended by the manufacturer (Pharmacia 
Fine Chemicals) and packed into a 1.2 x 6 cm col- 
umn. The radioactive material was applied to this 
column in 0.1 M Na2HP04 (pH 7.0) and after ex- 
tensive washing with the same buffer the adsorbed 
peptide was eluted with 1 N acetic acid. The eluate 
(18% of the applied radioactivity) was collected in 
2 M Tris-HCI (pH 8.6) and desalted on Sep-Pak 
Cl8 (Waters), which was equilibrated with water. 
After washing the cartridge with 10 ml water and 
5 ml 20% methanol, the HA was eluted with 80% 
methanol. This purified tritiated peptide was 
analysed for homogeneity on HPLC using a col- 
umn Cs (Li Chrosorb, particle size 7 pm, column 
size 250 x 4 mm) and a 10 min gradient from 
20-40% acetonitrile/O. 1Vo trifluoroacetic acid. 
The specific activity was found to be 
40-60 Ci/mmol. 
2.4. Preparation of fragrnen ts 
Peptides 2 and 5 (table 1) were produced by in- 
cubating 10 nmol of HA with TPCK-trypsin 
(50/1g/ml, Worthington) for 2 h in 0.05 M 
N&AC, pH 7.6 at 37°C. Peptides 3 and 4 were 
generated by digestion of the HA with Astacus en- 
dopeptidase [6] in 0.01 M Tris/O.l M NaCl pH 7.5 
at 37°C for 18 h (lOpg/ml). The fragments were 
resolved on HPLC (conditions as in section 2.3) 
and analysed for the amino acid composition after 
hydrolysis and dansylation according to [7]. 
2.5. Radioimmunoassay 
The incubation buffer for the RIA was 40 mM 
sodium phosphate (pH 7.4) containing 2.5 mg/ml 
bovine serum albumin, 6 mg/ml NaCl and 
1 mg/ml sodium azide. Peptide standard or 
unknown sample were incubated at 4°C for 4 h 
with the antiserum (1: 1500) in a total volume of 
450~1. After a further incubation of 4 h with the 
tracer (1200 cpm), 30 ,~l goat anti rabbit serum 
were added, together with 20~1 normal rabbit 
serum (1:500 final dilution), for precipitation. 
After 18 h the assay tubes were centrifuged for 
30 min at 4°C at 2000 x g and 350 pl of the super- 
natant were counted in a Kontron MR 300 beta 
counter. 
2.6. Extraction of HA from tissues 
Tissues were homogenised in a g-fold excess 
(w/w) of ice-cold methanol. After keeping this 
homogenate for 30 min at WC, a supernatant was 
obtained by centrifugation at 2000 x g for 20 min 
at 4°C. This supernatant was condensed to 0.5 ml 
and applied to a Sep-Pak Cis cartridge as in section 
2.3. The 80% methanol fraction was condensed 
and either directly used for the RIA or after a fur- 
ther purification on HPLC. 
Purification on HPLC was carried out on a 
semi-preparative reverse phase column (Cs, 5 pm 
particle size, 250 x 10 mm) with a gradient as in 
section 2.3. The retention time of the HA was 
determined with a small amount of tritiated pep- 
tide. Column fractions were evaporated and 
resuspended in 1 ml incubation buffer for the 
RIA. 
Table 1 
Cross-reactivity studies of head activator antiserum with head activator fragments and related 
peptides (Dhp: dehydroproline) 
Peptide Structure 
pGlu-Pro -Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe 
pGlu-Pro -Pro-Gly-Gly-Ser-Lys 
pGlu-Pro -Pro -Gly 
Ser-Lys-Val-Ile-Leu-Phe 
Val-Be-Leu-Phe 
Glu-Pro -Pro -Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe 
Glu-Dhp-Dhp-Gly-Gly-Ser-Lys-Val-Be-Leu-Phe 
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg 
Yo Immunoreactivity 
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3. RESULTS AND DISCUSSION 
The sensitivity of a RIA is highly dependent on 
the quality of the tracer used. Since the binding ef- 
ficiency of the unpurified tritiated tracer was very 
low (15% under the conditions in section 2.5), we 
decided to purify this crude tritiated product on an 
affinity column having the same immunoglobulins 
bound as used in the RIA. This was shown to be 
useful, since only 18% of the applied radioactivity 
bound to the fixed antibodies. It is obvious, that 
during the tritiation many side products were pro- 
duced which are not recognised by the antibodies, 
although they elute to a great part at the same 
place on HPLC as the HA does. After this 
purification step the binding capacity in the RIA 
raised from 15-45070. 
The production of antibodies against the HA is 
difficult, probably due to the weak immunogenici- 
ty of its amino acids. However, after application 
of the immunogenic conjugate directly into the 
lymphnodes one rabbit produced an antiserum 
which after 3 boosters reacted with tritiated HA. 
As found in the antiserum dilution curve, this 
serum 12/4 bound 45% of the tracer (1200 cpm 
added) at a dilution of 1: 1500. This value was 
already obtained after 4 h and did not change with 
longer incubation times. A typical displacement 
curve with affinity purified tracer and synthetic 
HA is presented in fig.1. It is apparent that the 
assay is sensitive in 40-200 fmol range. 
The specificity of the antiserum was characteris- 
ed by means of carboxy-terminal and amino- 
terminal fragments, which have been produced by 
enzymatic digestion of synthetic HA either with 
trypsin (peptides 2 and 5) or with Astucus en- 
dopeptidase (peptides 3 and 4). The intact HA 
(peptide 1) was found to be most effective in 
displacing the tritiated peptide (table 1). With 
bradykinin (peptide 8), which has some sequence 
homology at the amino-terminal end with the HA, 
the cross-reactivity was < 0.1%. When carboxy- or 
amino-terminal ends of the HA were missing, the 
ability to bind to the antiserum decreased more or 
less drastically. Peptide 2 missing the carboxy- 
terminal end had a cross-reactivity of 50’70, 
whereas peptide 4 missing the amino-terminal end 
was only 10% as effective as the intact HA. Fur- 
ther shortening of the peptide chains resulted in a 
more significant decrease of immunoreactivity. 
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Fig. 1. Comparison of the displacement curves produced 
by HA extracted from 4 x 104 hydras before (A) and 
after HPLC (0) to that of synthetic HA (0). The 
extracts were prepared as in section 2.6 and dissolved in 
1 ml RIA buffer. Each tube contained 1200 cpm of 
tritiated HA and serum 12/4 at a dilution of 1: 1500. 
After substitution of pGlu by Glu (peptide 6), the 
binding capacity was < 1%. From these results we 
can conclude, that the antiserum 12/4 binds 
preferentially to the amino-terminal portion of the 
HA and less to the carboxy-terminal portion. This 
is not surprising since the amino-terminal end of 
the HA remained free during the preparation of 
the antigenic conjugate by the carbodiimide 
method so that it represents most probably the ma- 
jor immunogenic determinant of the peptide in this 
conjugate. The extremely bad displacing capacity 
of peptide 6 having Glu instead of pGlu at the 
amino-terminal end indicates the special role of 
pGlu for the overall structure of the HA. 
As a first application of the RIA we determined 
the amount of HA-like immunoreactivity present 
in rat intestines and hydra. The preparation of HA 
from these tissues included methanol extraction 
and reverse-phase chromatography. With a g-fold 
excess of methanol during the extraction most of 
the proteins were precipitated. After this very po- 
tent purification step the methanol soluble HA was 
desalted on Sep-Pak and was directly assayed in 
the RIA. With this extraction procedure we 
isolated 60 pmol immunoreactive material/rat in- 
testine and 0.4 fmol/hydra. For a further purifica- 
tion we applied this material to HPLC with gra- 
dient elution. From both extracts we could detect 
one major peak of immunoreactivity, which ap- 
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Fig.2. Reverse phase HPLC of peptide extracts of 104 
hydras (A) and one rat intestine (B) on a CS column 
(250 x 10 mm) with acetonitrile/trifhtoroacetic acid as 
mobile phase. The flow rate was 4 ml/min, the fraction 
size 8 ml. The column was calibrated with tritiated head 
activator ( ---+ ). The content of head activator-like 
immunoreactivity (HA-LI) was measured. 
peared exactly with the same retention time as the 
synthetic HA does (fig.& From the hydra extract 
84% of the applied ~munoreacti~ty appeared at 
the HA position, from the intestinal extract 77% 
had the same retention time. The competition lines 
of these HPLC purified extracts were parallel to 
the HA line (fig. 1, not shown for the intestinal ex- 
tract). With this additional purification on HPLC 
we could demonstrate, that the major im- 
munoreactivity found in the RIA with this extrac- 
tion procedure was most probably due to HA as 
such. The nature of the residual immunoreactive 
products remains to be determined. 
From the comparison of the biological activity 
of synthetic HA with the biological activity con- 
tamed in one hydra we expected one hydra to con- 
tain <l fmol. The results obtained by the RIA 
measuring the immune-like reactivity indicate a 
good correspondence with these values from the 
bioassay. From the bioassay we also concluded, 
that one rat intestine contained 105-lo6 hydra 
equivalents of HA [8), which is also in good agree- 
ment to the results obtained by the RIA. The good 
correspondence of these values means that the RIA 
is now a reliable method for quantitative HA 
determinations. 
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